ArticleHIV medicine2026

Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system.

Leidan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.